CoChat

Anti-CTLA-4 treatment induces IL-10-producing ICOS + regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis

Open access
Coquerelle, C, Oldenhove, G, Acolty, V, Denoeud, J, Vansanten, G, Verdebout, J-M, Mellor, A, Bluestone, J A, Moser, M · 2009 · Gut
Cited by 71

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Background and aims: Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) has been shown to act as a negative regulator of T cell function and has been implicated in the regulation of T helper 1 (Th1)/Th2 development and the function of regulatory T cells. Tests were carried out to determine whether anti-CTLA-4 treatment would alter the polarisation of naive T cells in vivo. Methods: Mice were treated with anti-CTLA-4 monoclonal antibody (mAb) (UC10-4F10) at the time of immunisation or colonic instillation of trinitrobenzene sulfonic acid (TNBS). The cytokines produced by lymph node cells after in vitro antigenic stimulation and the role of indoleamine 2,3 dioxygenase (IDO) and of interleukin-10 (IL-10) were tested, and the survival of mice was monitored. Results: Injection of anti-CTLA-4 mAb in mice during priming induced the development of adaptive CD4 + regulatory T cells which expressed high levels of ICOS (inducible co-stimulator), secreted IL-4 and IL-10. This treatment inhibited Th1 memory responses in vivo and repressed experimental intestinal inflammation. The anti-CTLA-4-induced amelioration of disease correlated with IDO expression and infiltration of ICOS high Foxp3 + T cells in the intestine, suggesting that anti-CTLA-4 acted indirectly through the development of regulatory T cells producing IL-10 and inducing IDO. Conclusions: These observations emphasise the synergy between IL-10 and IDO as anti-inflammatory agents and highlight anti-CTLA-4 treatment as a potential novel immunotherapeutic approach for inducing adaptive regulatory T cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gut.2008.162842

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 71

Metadata

Authors
Coquerelle, C., Oldenhove, G., Acolty, V, Denoeud, J., Vansanten, G., Verdebout, J.-M., Mellor, A., Bluestone, J. A., & Moser, M.
Venue
Gut
Publisher
BMJ
Published
2009-06-07
Volume
58
Issue
10
Pages
1363-1373
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2005956916
Cited by
71
References
13
FWCI
3.18
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anti-CTLA-4 treatment induces IL-10-producing ICOS + regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis. https://app.cochat.ai/papers/10.1136/gut.2008.162842
The paper
Coquerelle, C., Oldenhove, G., Acolty, V, Denoeud, J., Vansanten, G., Verdebout, J.-M., Mellor, A., Bluestone, J. A., & Moser, M. (2009). Anti-CTLA-4 treatment induces IL-10-producing ICOS + regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis. Gut. https://doi.org/10.1136/gut.2008.162842

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.